CD8A and neoplasm: Vaccination elicited potent adaptive immune responses by improving the extension and infiltration of OVA-specific CD8+ T cells in OVA-expressing syngeneic allograft mouse models of prostate cancer and suppressed tumor growth when offered postengraftment (60% reduction vs. control).